Mortality by infarction is lower in men and higher in women

In the last decades, mortality by MI infarction has seen a reduction in men but keeps increasing in women and one of the reasons points out symptoms are more visible in men, which results in better and effective treatment for men.

According to official data, a total of 380,000 women suffer heart attacks in the US every year; this happens every 90 seconds and, every two minutes, one of these patients dies.

Symptoms in men are better identified by the general public: oppressive chest pain shooting from the left side to the jaw and left arm. Women tend to detect infarction symptoms four hours later than men. Both women and doctors do not recognize symptoms effectively and appropriately and this delays proper treatment. Obesity and diabetes also favor the increase of heart attacks and reduces incidence by age. 

Source

SOLACI.ORG

More articles by this author

Women Present Lower Risk of Sport Related Sudden Death Compared to Men

According to this recent analysis published in Eur Heart J, women would have a far lower chances of dying suddenly for physical exertion during...

Saturated Fats: Dietary Angels or Demons?

In order to reduce cardiovascular events, dietary guidelines recommend restricting saturated fatty acids—without taking into account differences among them—to <10% of the daily caloric...

Low-Carb Diet and Coronary Artery Calcium Progression

People on low carb diets since a young age present increased risk of coronary artery calcium progression, particularly when carbs are replaced by animal...

Number of Hours of Sleep and Risk of Stroke

Sleep duration (either short or long) affect the risk of stroke according to this recent analysis. We had visited a study published in JACC...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...